Home › Funds › Nantahala Capital Management, LLC › SVRA

Nantahala Capital Management, LLC position in SVRA

SAVARA INC · Health Care

Nantahala Capital Management, LLC reported holding 7,137,159 shares of SVRA (SAVARA INC) in its Q3 2026 13F filing — a position valued at US$36.8M, representing 1.69% of its reported portfolio and ranking #13 among its reported holdings. Nantahala Capital Management, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)7.14M sh
Reported value held$36.83M
Portfolio Weight1.69%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's SVRA position evolved

Nantahala Capital Management, LLC first disclosed a stake in SVRA in Q3 2023 at 1,039,364 shares (US$3.9M). The position peaked in Q4 2025 at 7,344,783 shares, worth US$44.3M. Across 13 filings, Nantahala Capital Management, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,137,159 shares valued at US$36.8M — an increase of 160,349 shares quarter over quarter.. Notable position changes include a 76% increase in Q1 2024 (shares fell 19% over the following quarter), a 198% increase in Q2 2024 (shares rose 5% over the following quarter), a 45% increase in Q4 2024 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $3.93M New
Q4 2023 987.90K $4.64M Reduce
Q1 2024 1.74M $8.65M Add
Q2 2024 5.18M $20.88M Add
Q3 2024 5.18M $21.97M Hold
Q4 2024 7.53M $23.10M Add
Q1 2025 8.08M $22.37M Add
Q2 2025 8.33M $18.98M Add
Q3 2025 8.78M $31.33M Add
Q4 2025 7.34M $44.29M Reduce
Q1 2026 7.34M $40.10M Hold
Q2 2026 6.98M $42.98M Reduce
Q3 2026 7.14M $36.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SVRA and 13F data

SVRA (SAVARA INC) is a Health Care company. 40 other funds we track also report a position in SVRA — the largest reported positions include NEA Management Company, LLC (US$150.7M), Bain Capital Life Sciences Investors, LLC (US$108.4M), Venrock Adviser, LLC (US$90.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SVRA

All SVRA fund holders →

FAQ

How long has Nantahala Capital Management, LLC held SVRA?

Nantahala Capital Management, LLC has disclosed SVRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nantahala Capital Management, LLC's current position in SVRA?

As of Q3 2026, Nantahala Capital Management, LLC holds 7.14M shares of SVRA (SAVARA INC), valued at $36.83M, representing 1.69% of its reported portfolio and ranking #13.

Has Nantahala Capital Management, LLC been buying or selling SVRA?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in SVRA. The position peaked in Q4 2025 at 7.34M shares.

Which other funds hold SVRA?

Other major institutional holders of SVRA include NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, Venrock Adviser, LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.